ENDOMETRIAL CARCINOMA (EC)
Clinical trials for ENDOMETRIAL CARCINOMA (EC) explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CARCINOMA (EC) trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA (EC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug could help immune system fight uterine and colon cancers before surgery
Disease control OngoingThis study tests a drug called TPST-1495 in 10 people with endometrial or colorectal cancer who are scheduled for surgery. The drug aims to boost the immune system's ability to fight cancer by blocking certain signals. Researchers will check blood and tumor samples before and aft…
Matched conditions: ENDOMETRIAL CARCINOMA (EC)
Phase: PHASE2 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
New pill targets rare cancer mutation in Late-Stage tumors
Disease control OngoingThis early-stage study tests an experimental pill, ATV-1601, for people with advanced solid tumors or certain breast cancers that have a specific AKT1 gene mutation. The main goals are to check the drug's safety, find the best dose, and see how the body processes it. About 134 ad…
Matched conditions: ENDOMETRIAL CARCINOMA (EC)
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC